Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
mTOR inhibitors in cancer therapy.
Zaytseva YY, Valentino JD, Gulhati P, Evers BM. Zaytseva YY, et al. Cancer Lett. 2012 Jun 1;319(1):1-7. doi: 10.1016/j.canlet.2012.01.005. Epub 2012 Jan 17. Cancer Lett. 2012. PMID: 22261336 Review.
Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
Talbert DR, Allred CD, Zaytseva YY, Kilgore MW. Talbert DR, et al. Among authors: zaytseva yy. Breast Cancer Res Treat. 2008 Mar;108(1):23-33. doi: 10.1007/s10549-007-9575-y. Epub 2007 Apr 24. Breast Cancer Res Treat. 2008. PMID: 17453334
Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.
Zaytseva YY, Wang X, Southard RC, Wallis NK, Kilgore MW. Zaytseva YY, et al. Mol Cancer. 2008 Dec 5;7:90. doi: 10.1186/1476-4598-7-90. Mol Cancer. 2008. PMID: 19061500 Free PMC article.
The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
Zaytseva YY, Wallis NK, Southard RC, Kilgore MW. Zaytseva YY, et al. Anticancer Res. 2011 Mar;31(3):813-23. Anticancer Res. 2011. PMID: 21498701
The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON.
Silva SR, Zaytseva YY, Jackson LN, Lee EY, Weiss HL, Bowen KA, Townsend CM Jr, Evers BM. Silva SR, et al. Among authors: zaytseva yy. Anticancer Res. 2011 Apr;31(4):1153-60. Anticancer Res. 2011. PMID: 21508359 Free PMC article.
Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
Zaytseva YY, Rychahou PG, Gulhati P, Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL, Lee EY, Evers BM. Zaytseva YY, et al. Cancer Res. 2012 Mar 15;72(6):1504-17. doi: 10.1158/0008-5472.CAN-11-4057. Epub 2012 Jan 19. Cancer Res. 2012. PMID: 22266115 Free PMC article.
Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.
Gulhati P, Zaytseva YY, Valentino JD, Stevens PD, Kim JT, Sasazuki T, Shirasawa S, Lee EY, Weiss HL, Dong J, Gao T, Evers BM. Gulhati P, et al. Among authors: zaytseva yy. Carcinogenesis. 2012 Sep;33(9):1782-90. doi: 10.1093/carcin/bgs203. Epub 2012 Jun 13. Carcinogenesis. 2012. PMID: 22696593 Free PMC article.
Novel small interfering RNA cotargeting strategy as treatment for colorectal cancer.
Valentino JD, Elliott VA, Zaytseva YY, Rychahou PG, Mustain WC, Wang C, Gao T, Evers BM. Valentino JD, et al. Among authors: zaytseva yy. Surgery. 2012 Aug;152(2):277-85. doi: 10.1016/j.surg.2012.05.006. Surgery. 2012. PMID: 22828149 Free PMC article.
Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors.
Valentino JD, Li J, Zaytseva YY, Mustain WC, Elliott VA, Kim JT, Harris JW, Campbell K, Weiss H, Wang C, Song J, Anthony L, Townsend CM Jr, Evers BM. Valentino JD, et al. Among authors: zaytseva yy. Clin Cancer Res. 2014 Mar 1;20(5):1212-22. doi: 10.1158/1078-0432.CCR-13-1897. Epub 2014 Jan 17. Clin Cancer Res. 2014. PMID: 24443523 Free PMC article.
Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.
Zaytseva YY, Elliott VA, Rychahou P, Mustain WC, Kim JT, Valentino J, Gao T, O'Connor KL, Neltner JM, Lee EY, Weiss HL, Evers BM. Zaytseva YY, et al. Carcinogenesis. 2014 Jun;35(6):1341-51. doi: 10.1093/carcin/bgu042. Epub 2014 Feb 7. Carcinogenesis. 2014. PMID: 24510238 Free PMC article.
27 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page